146 results on '"Bijnsdorp, Irene V."'
Search Results
2. Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines
3. A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based Proteomics
4. Secreted protein markers in oral squamous cell carcinoma (OSCC)
5. Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model
6. Secretome processing for proteomics: A methods comparison.
7. Large pan-cancer cell screen coupled to (phospho-) proteomics underscores high-dose vitamin C as a potent anti-cancer agent
8. Longitudinal stability of urinary extracellular vesicle protein patterns within and between individuals
9. Changes in the urinary extracellular vesicle proteome are associated with nephronophthisis-related ciliopathies
10. Hollow Fiber Assay
11. Supplementary Data from Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2
12. Protein Kinase D Drives the Secretion of Invasion Mediators in Triple-Negative Breast Cancer Cell Lines
13. Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer
14. The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice
15. Hollow Fiber Assay
16. Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension
17. Additional file 1 of Secreted protein markers in oral squamous cell carcinoma (OSCC)
18. Hollow Fiber Assay
19. [18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells
20. Abstract CC03-01: Exosome pathway inhibition as therapeutic strategy in colorectal cancer
21. Abstract 6931: Epigenetic Modification of the Von Willebrand Factor Promotor Drives in situ Thrombosis in Chronic Thromboembolic Pulmonary Hypertension
22. Secreted Protein Markers in Oral Squamous Cell Carcinoma (Oscc)
23. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells
24. Hollow Fiber Assay
25. Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer
26. Lipopolysaccharide‐regulated secretion of soluble and vesicle‐based proteins from a panel of colorectal cancer cell lines
27. Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles
28. Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine
29. Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells
30. Analysis of Drug Interactions
31. DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery
32. DPHL: A pan-human protein mass spectrometry library for robust biomarker discovery
33. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells#
34. Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines
35. Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
36. Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome
37. Abstract 1085: Prostate cancer secreted microRNAs influence early steps in bone metastasis via osteoclast precursors
38. Large-Scale Urinary Proteome Dataset Across Tumor Types Reveals Candidate Biomarkers for Lung Cancer
39. Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method
40. Protein Complexes in Urine Interfere with Extracellular Vesicle Biomarker Studies
41. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110
42. [18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells
43. Hollow Fiber Assay
44. Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes
45. Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: Clinical implications and molecular correlates
46. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients
47. TAS-102: more than an antimetabolite
48. Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer
49. Lipophilic Prodrugs and Formulations of Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
50. Abstract LB-14: Low connexin-26 predicts the development of metastasis after radical prostatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.